SC 13D
SCHEDULE 13D
- Company
- NORTHWEST BIOTHERAPEUTICS INC
- Filed
- May 6, 2004
- Accession Number
- 0000950133-04-001829
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →